Literature DB >> 8780803

Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change.

J T Povlishock1, E H Pettus.   

Abstract

Recent studies have demonstrated that delayed or secondary axotomy is a consistent feature of traumatic brain injury in both animals and man. Moreover, these studies have shown that the pathogenesis of this secondary axotomy involves various forms of initiating pathology, with the suggestion that, in some cases, only the axonal cytoskeleton is perturbed, while, in other cases, both the axonal cytoskeleton and related axolemma manifest traumatically induced perturbations. In the current communication, we continue in our investigation of the significance of these traumatically induced alterations in axolemmal permeability and their relation to any related intra-axonal cytoskeletal change. This was accomplished in cats which received intrathecal infusions of peroxidase, an agent normally excluded by the intact axolemma. These animals were subjected to traumatic brain injury, and sites showing altered axolemmal permeability to the peroxidase were assessed at the light and electron microscopic level. Through this approach, we recognized that a traumatic episode of moderate severity evoked changes in axolemmal permeability which surprising endured for up to 5 hrs postinjury. At such focal sites of altered permeability, the related cytoskeleton showed a statistically significantly neurofilament compaction, with the strong suggestion of concomitant neurofilament sidearm loss, microtubular dispersion, and mitochondrial abnormality. Over time, these events led to further disorganization of the axonal cytoskeleton which translated into impaired axoplasmic transport and secondary axotomy. Most likely, these alterations in axolemmal permeability result in either the direct or indirect effects upon the axonal cytoskeleton that precipitate the damaging sequences resulting in delayed axotomy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780803     DOI: 10.1007/978-3-7091-9465-2_15

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  34 in total

1.  The nature of concussion: a speculative hypothesis.

Authors:  P McCrory
Journal:  Br J Sports Med       Date:  2001-06       Impact factor: 13.800

Review 2.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

3.  Ultrastructure of Diaschisis Lesions after Traumatic Brain Injury.

Authors:  Clayton A Wiley; Stephanie J Bissel; Andrew Lesniak; C Edward Dixon; Jonathan Franks; Donna Beer Stolz; Ming Sun; Guoji Wang; Robert Switzer; Patrick M Kochanek; Geoffrey Murdoch
Journal:  J Neurotrauma       Date:  2016-03-30       Impact factor: 5.269

Review 4.  Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench.

Authors:  Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

5.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

6.  A novel PARP inhibitor L-2286 in a rat model of impact acceleration head injury: an immunohistochemical and behavioral study.

Authors:  Erzsébet Kövesdi; Péter Bukovics; Valérie Besson; József Nyirádi; János Lückl; József Pál; Balázs Sümegi; Tamás Dóczi; István Hernádi; András Büki
Journal:  Int J Mol Sci       Date:  2010-03-26       Impact factor: 5.923

7.  Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.

Authors:  Sarabjit K Saggu; Hiren P Chotaliya; Peter C Blumbergs; Robert J Casson
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

8.  PEG-PDLLA micelle treatment improves axonal function of the corpus callosum following traumatic brain injury.

Authors:  Xingjie Ping; Kewen Jiang; Seung-Young Lee; Ji-Xing Cheng; Xiaoming Jin
Journal:  J Neurotrauma       Date:  2014-05-13       Impact factor: 5.269

9.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

10.  The Neurometabolic Cascade of Concussion.

Authors:  Christopher C. Giza; David A. Hovda
Journal:  J Athl Train       Date:  2001-09       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.